A Comparison of US and EU Biosimilars Regimes

This article presents an overview of the US and EU biosimilars regulations, in order to help legal and executive decision makers at biopharmaceutical companies begin to think about the range of expenditures that may be necessary for approval of a biosimilar. Read the full article.


Don’t have an account yet?